Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2025-12-24 @ 11:37 PM
NCT ID:
NCT05586256
Eligibility Criteria:
Inclusion Criteria:
* Female patients
* Age ≥ 18 years.
* Early stage breast cancer treated with breast conserving surgery
* Whole breast irradiation without regional nodal irradiation
* Infiltrating carcinomas
* CDIS
* Written informed consent
Exclusion Criteria:
* Age\<18 years.
* Regional nodal radiotherapy.
* Distant metastases.
* Previous history of malignancy except basaloid skin tumours and CIN. Previous history of breast cancer is not an exclusion criteria if treated with curative intent and if patient is disease free at least 5 years from diagnosis.
* Presence of absolute radiotherapy contraindications (pregnancy, inability to maintain the correct treatment position) and relative radiotherapy contraindications (connective tissue diseases including rheumatoid arthritis, scleroderma, systemic lupus erythematosus, dermatomyositis and vasculitis, especially if the disease is in an active phase)
* Patient's refusal to use data for research purposes.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT05586256
Study Brief:
Protocol Section:
NCT05586256